BETTINA ENGH: Open Payments
NPI 1104027184 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,508 in 137 payments from 27 companies in 2025. Trend: 2023 $3,431 · 2024 $2,768 · 2025 $3,508
Food & beverage: $3,508
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $540 |
| BETA BIONICS, INC. | 11 | $470 |
| Abbott Laboratories | 16 | $406 |
| Sequel Med Tech, LLC | 8 | $357 |
| Medtronic, Inc. | 5 | $253 |
| Lilly USA, LLC | 12 | $237 |
| Xeris Pharmaceuticals, Inc. | 9 | $195 |
| Insulet Corporation | 8 | $163 |
| Amgen Inc. | 10 | $157 |
| Chiesi USA, Inc. | 4 | $95 |
Products named: iLet Bionic Pancreas, FREESTYLE LIBRE 3, TWIIST, Ozempic, MINIMED 780G, GVOKE HYPOPEN, JARDIANCE, Wegovy.
Industry payments across TN — which companies pay providers there.
